Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of honokiol capsule in China. Welcome to wholesale bulk high quality honokiol capsule for sale here from our factory. Good service and reasonable price are available.
Honokiol capsules provide a standardized and user-friendly way to consume honokiol, a bioactive compound derived from magnolia bark with anti-inflammatory, neuroprotective, and anxiolytic properties. Unlike raw powder, capsules ensure precise dosing, enhance stability, and improve bioavailability through optimized formulations, such as lipid-based or nano-emulsion delivery systems. The encapsulation protects honokiol from degradation due to light, moisture, and oxidation, extending shelf life. Additionally, capsules mask the bitter taste of honokiol, improving patient compliance. They are particularly beneficial for individuals seeking consistent dosing for stress relief, cognitive support, or metabolic health. Advanced capsule technologies, including delayed-release or enteric-coated variants, further enhance absorption and therapeutic efficacy, making honokiol capsules a preferred choice for both consumers and clinical applications.
|
|
|
Honokiol Powder COA
Core Raw Materials and Auxiliary Materials Selection
Main Component
Honokiol (and honokiol) is the active ingredient and must meet high purity requirements (≥98%) and low impurity standards. Its extraction process typically uses ethanol reflux method or supercritical CO₂ extraction method. The latter is gradually becoming the mainstream due to its no solvent residue and high retention rate of active ingredients (up to 95% or more).
Auxiliary Material System
Gelatin: As the main film-forming material for capsules, it should be selected as pharmaceutical-grade gelatin (A-type or B-type). The isoelectric point should match the stability of the drug (e.g., the isoelectric point of B-type gelatin is pH 4.7-5.2, which is more suitable for acidic environment drugs).
Plasticizer: Glycerol or sorbitol, with a dosage of 40%-60% of gelatin, to adjust the flexibility of the capsule shell. For example, in the case of tiger nut oil soft capsules, the ratio of glycerol to gelatin is 1:2, ensuring the elasticity of the capsule shell at low temperatures.
Light Absorber: Titanium dioxide (dosage 0.1%-0.5%), used to protect photosensitive drugs (such as Honokiol needs to be stored in the dark).
Antioxidant: Vitamin E (0.01%-0.1%), to prevent drug oxidation and degradation.
Capsule Shell Preparation Process
Gelation and Defoaming
Gelation: Mix gelatin, plasticizer, and water in proportion, heat to 60-80°C and stir to dissolve. For example, in the gelation process of Australian nut oil capsules, the mixture of sorbitol and water needs to be stirred for 15 minutes to be uniform, then add gelatin and stir for another 30 minutes.
Defoaming: Remove air bubbles in the gel solution through vacuum degassing (pressure -50Pa to -80Pa) to avoid defects on the capsule surface. The defoaming process of tiger nut oil soft capsules requires maintaining a temperature of 65°C and a vacuum degree of -50Pa for 2 hours.
Capsule Shell Formation
Drop Casting Method: Drop the gel solution and drug solution through double-layer drop heads into the cooling liquid (such as liquid paraffin) to form spherical soft capsules. For example, in the preparation of vitamin AD capsules, the gelatin solution and fish liver oil drug solution are dropped at 135°C, and then cooled to form seamless capsules.
Compression Method: Place the drug solution between two layers of gel sheets and use a mold to shape. This method is suitable for non-oily drug solutions (such as PEG400 solution), but the mold temperature (20-30°C) needs to be controlled to prevent film adhesion.
Drug Filling and Packaging
Filling Equipment and Process
Hard Capsule Filling: Use stroke quantitative method or filling quantitative method, and complete the filling through a capsule filling machine (such as the German Bosch GKF series). For example, the filling capacity of No. 0 hard capsules is 0.40-0.75 mL, and the specification needs to be selected according to the drug bulk density.
Soft Capsule Filling: The drug solution needs to be adjusted to an appropriate viscosity (1000-5000 cP), and be encapsulated through a rotary die press or drop casting machine. In the filling process of Australian nut oil capsules, the drug solution needs to be vacuum degassed for 40 minutes at 60°C to reduce the impact of air bubbles on the filling volume.
Packaging Quality Control
Filling Variability: The filling variability limit for hard capsules is ±7.5% (≥0.3g) or ±10% (<0.3g); soft capsules need to be controlled within ±5%.
Sealing: Locking-type hard capsules ensure sealing through mechanical locking; soft capsules need to be shaped and dried by a roller dryer (temperature 20-35°C, humidity 18%-20%) to avoid leakage.
Optimization of Key Process Parameters
Drying Conditions
After hard capsule filling, it needs to be dried at 30-40°C for 2-4 hours to remove moisture and prevent capsule deformation.
Soft capsule drying needs to be carried out in stages: initial drying (20°C, 3 hours) to remove surface moisture, and final drying (30°C, 2 hours) to ensure the core moisture ≤8%.
Stability Enhancement
Nanoparticle Encapsulation: Through β-cyclodextrin encapsulation technology to increase the solubility of Honokiol (solubility increased by more than 10 times), while reducing the first-pass effect. Enteric-coated capsules: They are coated with acrylic resin No. 2, ensuring that the capsules do not disintegrate in gastric fluid for 2 hours and are completely released in intestinal fluid within 60 minutes.
Frontier advancements in patented technologies and innovative formulations
Honokiol capsule, as a polyphenolic compound derived from plants of the Magnoliaceae family, has become a hot topic in global drug research due to its remarkable anti-cancer, anti-inflammatory and immune-regulating activities. However, its strong hydrophobicity, low bioavailability, and easy degradation in the body have severely limited its clinical application. In recent years, through the development of nanotechnology, targeted delivery systems and innovative formulations, the clinical transformation of honokiol has achieved breakthrough progress. A number of patented technologies and innovative formulations have provided new solutions for the treatment of cancer, autoimmune diseases and metabolic disorders.
Patent Technology Breakthrough: Enhancing Stability and Targeting
Nanoparticle Encapsulation and Liposome Delivery
In response to the hydrophobic nature of and honperol, the patent technology significantly enhances its solubility through β-cyclodextrin encapsulation or liposome encapsulation. For instance, a patent utilizes the hydroxypropyl-β-cyclodextrin encapsulation technique, increasing the solubility of and honperol by more than 10 times. The particle size is controlled within 200 nm, and the drug release rate in the intestine is increased to 90%, with the bioavailability improving by 3 times compared to traditional formulations. The liposome delivery system extends the drug half-life through PEG modification, and animal experiments show that the accumulation of this formulation in tumor tissues is 5.2 times that of free drugs, and the inhibition rate for melanoma models reaches 78%.
Enteric Coating and pH-Responsive Release
To address the sensitivity of and honperol to light, heat, and acidic environments, the patent technology employs acrylic resin No. 2 for coating, ensuring that the capsules do not disintegrate in gastric fluid for 2 hours and fully release in intestinal fluid within 60 minutes. For example, the intestinal-coated capsules developed by a certain enterprise show a release curve in simulated intestinal fluid, with a cumulative release amount reaching 95% within 120 minutes, significantly higher than the 40% of ordinary capsules, and the transmembrane rate of Caco-2 cells increases to 85%.
Combination Therapy and Signal Pathway Regulation
And honperol exhibits anti-angiogenic and pro-apoptotic activities by inhibiting Akt activation, blocking VEGF-VEGFR2 interaction, and regulating the NF-κB pathway. The patent technology combines it with immune checkpoint inhibitors (such as pembrolizumab), and animal experiments show that the inhibition rate for non-small cell lung cancer reaches 92%, significantly higher than the 68% of single drug treatment.
Innovative Formulation Development: Meeting Diverse Clinical Needs
Self-microemulsifying Soft Capsules
In response to the poor water solubility of and honperol, the patent technology employs a self-microemulsifying system (such as oleic acid ethyl ester, polysorbate 80) to form microemulsions with particle sizes < 50 nm. This formulation shortens the dispersion time in 37°C water to 30 seconds, increases the transmembrane rate of Caco-2 cells to 85%, and shows a 2.3-fold increase in oral bioavailability compared to traditional formulations.
Targeted Microsphere Injection
To prolong the drug's action time, the patent technology uses poly(lactic-co-glycolic acid) (PLGA) to prepare microsphere injections. By regulating the molecular weight (50,000-100,000 Da) and drug loading (10%-20%), the drug is continuously released in the body for up to 21 days, and the inhibitory effect on prostate cancer cells is prolonged by 3 times compared to free drugs.
Transdermal Patch and Local Administration
For chronic diseases such as arthritis, the patent technology developed a and honperol transdermal patch, using silicone pressure-sensitive gel matrix for non-invasive drug delivery. The in vitro permeation experiment shows that the cumulative permeation amount of this patch reaches 12 mg/cm² within 24 hours, inhibiting the paw swelling of rats induced by carrageenan by 65%, and showing no skin irritation.
Frontier Research Directions: Intelligent Delivery and Clinical Translation
pH/Ester Dual-Responsive Delivery System
In response to the characteristics of the tumor microenvironment, the patent technology designs chitosan-hyaluronic acid composite microspheres, which trigger drug release in the acidic environment of tumors (pH 5.0-6.5) and the presence of hyaluronidase. The experiments show that the uptake rate of this formulation by breast cancer cells increases to 90%, and the toxicity to normal cells is reduced by 60%.
3D Printing Personalized Capsules
Using 3D printing technology (such as FDM process), the patent technology enables personalized customization of and honperol capsules. By regulating the print layer thickness (0.1-0.3 mm) and drug distribution, capsules with sustained-release, pulse-release functions can be prepared to meet the treatment needs of different patients.
Challenges and Prospects
Although significant progress has been made in the nano-formulation and innovative dosage forms of honokiol capsule, further breakthroughs are still needed in the optimization of its large-scale production process, long-term safety assessment, and clinical data transparency. In the future, with the integration of technologies such as AI drug development and gene editing, the precise delivery system and combined therapy of honokiol are expected to accelerate clinical translation, providing more efficient and safe treatment options for patients with cancer, autoimmune diseases, and metabolic disorders.
Frequently asked questions
Q:What is honokiol used for?
Honokiol is known for its anxiolytic (6–9), analgesic (10), antidepressant (11, 12), antithrombotic (13), antimicrobial (14–16), antispasmodic (17), anti-tumorigenic, and neuroprotective properties
How much honokiol for sleep?
Honokiol at doses of 10 and 20 mg·kg−1 was found to increase NREM sleep by 2.5- and 3.8-fold and to decrease the total amount of wakefulness by 27% and 43%, respectively, as compared with the baseline values (Figure 2E).
Is honokiol good for anxiety?
Moreover, honokiol has been studied for its anti-anxiety and sedative effects, which have been traditionally recognized in East Asian medicine. It modulates the gamma-aminobutyric acid (GABA) receptors in the brain, leading to calming effects, which could be beneficial for anxiety disorders and insomnia.
Hot Tags: honokiol capsule, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale